1.19
price down icon1.65%   -0.02
 
loading
Zenvia Inc stock is traded at $1.19, with a volume of 7,439. It is down -1.65% in the last 24 hours and down -17.36% over the past month. Zenvia Inc provides a platform that enables companies to create unique journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.
See More
Previous Close:
$1.21
Open:
$1.22
24h Volume:
7,439
Relative Volume:
0.33
Market Cap:
$62.76M
Revenue:
$151.37M
Net Income/Loss:
$-36.78M
P/E Ratio:
-1.2445
EPS:
-0.9562
Net Cash Flow:
$25.70M
1W Performance:
-16.14%
1M Performance:
-17.36%
6M Performance:
-41.67%
1Y Performance:
-14.39%
1-Day Range:
Value
$1.15
$1.235
1-Week Range:
Value
$1.15
$1.40
52-Week Range:
Value
$0.80
$3.8799

Zenvia Inc Stock (ZENV) Company Profile

Name
Name
Zenvia Inc
Name
Phone
-
Name
Address
-
Name
Employee
1,076
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
ZENV's Discussions on Twitter

Zenvia Inc Stock (ZENV) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-21-22 Downgrade Itau BBA Outperform → Market Perform
Aug-23-21 Initiated Itau BBA Outperform
Aug-16-21 Initiated Goldman Buy

Zenvia Inc Stock (ZENV) Latest News

pulisher
Nov 02, 2024

This Zenvia Insider Increased Their Holding By 964% Last Year - Simply Wall St

Nov 02, 2024
pulisher
Oct 29, 2024

Zenvia Inc(ZENV) Price Target Increased by 5.68% to 1.58 - MSN

Oct 29, 2024
pulisher
Oct 26, 2024

Zenvia Inc. (NASDAQ:ZENV) Short Interest Update - MarketBeat

Oct 26, 2024
pulisher
Oct 25, 2024

Zenvia Inc. (NASDAQ:ZENV) Q2 2024 Earnings Call Transcript - MSN

Oct 25, 2024
pulisher
Oct 21, 2024

Zenvia CMO Marcelo Wakatsuki steps down, interim named By Investing.com - Investing.com South Africa

Oct 21, 2024
pulisher
Oct 21, 2024

Zenvia Inc. Announces Leadership Change in Marketing - TipRanks

Oct 21, 2024
pulisher
Oct 21, 2024

Zenvia CMO Marcelo Wakatsuki steps down, interim named - Investing.com UK

Oct 21, 2024
pulisher
Oct 17, 2024

Zenvia establishes at-the-market equity programme in Brazil - Latin Lawyer

Oct 17, 2024
pulisher
Oct 16, 2024

Zenvia Customer Cloud hits the market with AI to revolutionize Brand-CX - Martechcube

Oct 16, 2024
pulisher
Oct 16, 2024

Zenvia Customer Cloud hits the market with AI to revolutionize Brand-Customer experiences - StockTitan

Oct 16, 2024
pulisher
Oct 13, 2024

Zenvia Inc. (NASDAQ:ZENV) Short Interest Up 24.6% in September - MarketBeat

Oct 13, 2024
pulisher
Sep 25, 2024

Zenvia Inc. (NASDAQ:ZENV) Short Interest Down 59.9% in September - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

Affinity Asset Advisors LLC Invests $3.84 Million in HilleVax, Inc. (NASDAQ:HLVX) - Defense World

Sep 25, 2024
pulisher
Sep 18, 2024

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Zenas BioPharma sees $15 million in stock purchases by Zebra Aggregator - Investing.com Canada

Sep 18, 2024
pulisher
Sep 18, 2024

Is this affordable and accessible eyewear brand worth the hype? - Reviewed

Sep 18, 2024
pulisher
Sep 18, 2024

Wedbush lifts Zentalis Pharmaceuticals Inc [ZNTL] price estimate. Who else is bullish? - The DBT News

Sep 18, 2024
pulisher
Sep 18, 2024

Trading Day Review: Zevra Therapeutics Inc (ZVRA) Loses Momentum, Closing at 7.53 - The Dwinnex

Sep 18, 2024
pulisher
Sep 18, 2024

Adversity is less terrifying than hope: Zentalis Pharmaceuticals Inc (ZNTL) - SETE News

Sep 18, 2024
pulisher
Sep 18, 2024

You might want to take a look at Zevra Therapeutics Inc (ZVRA) now - SETE News

Sep 18, 2024
pulisher
Sep 18, 2024

Potential Price Increase for Zentalis Pharmaceuticals Inc (ZNTL) After Recent Insider Activity - Knox Daily

Sep 18, 2024
pulisher
Sep 18, 2024

Daily Market Movement: Zentalis Pharmaceuticals Inc (ZNTL) Sees a 11.41 Increase, Closing at 4.10 - The Dwinnex

Sep 18, 2024
pulisher
Sep 18, 2024

Zenith UK appoints Sannah Rogers chief executive - CampaignLive

Sep 18, 2024
pulisher
Sep 18, 2024

Zendaya's baby pics that show she's always been that girl - Hindustan Times

Sep 18, 2024
pulisher
Sep 17, 2024

Zenas BioPharma director acquires $999k in company stock By Investing.com - Investing.com Canada

Sep 17, 2024
pulisher
Sep 17, 2024

FDA lifts partial clinical hold on Zentalis Pharma’s cancer WEE1 inhibitor - Pharmaceutical Technology

Sep 17, 2024
pulisher
Sep 17, 2024

Zevra Therapeutics Inc (ZVRA)’s stock decline to 7.78 per share - US Post News

Sep 17, 2024
pulisher
Sep 17, 2024

Zentalis Stock Up as FDA Lifts Partial Hold on Cancer Drug Studies - Zacks Investment Research

Sep 17, 2024
pulisher
Sep 17, 2024

Zeneara Reviews"HYPE-LEGIT" HAPPY Customer or Controversy? - openPR

Sep 17, 2024
pulisher
Sep 17, 2024

IPO Radar: Applied Nutrition, Zenas BioPharma, BingEx - The Armchair Trader

Sep 17, 2024
pulisher
Sep 17, 2024

Zenith Bank Rises Slightly after ‘Fund’ Amass Huge Shares - MarketForces Africa

Sep 17, 2024
pulisher
Sep 16, 2024

Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm - PR Newswire

Sep 16, 2024
pulisher
Sep 16, 2024

Zenas BioPharma director buys $7.48m in company stock By Investing.com - Investing.com South Africa

Sep 16, 2024
pulisher
Sep 16, 2024

Fairmount Healthcare Fund II L.P. buys $5.1m of Zenas BioPharma stock By Investing.com - Investing.com South Africa

Sep 16, 2024
pulisher
Sep 16, 2024

SR One Capital management buys $38m of Zenas BioPharma stock - Investing.com

Sep 16, 2024
pulisher
Sep 16, 2024

Understanding the Risks of Investing in Zevra Therapeutics Inc (ZVRA) - Knox Daily

Sep 16, 2024
pulisher
Sep 16, 2024

Zentalis Pharmaceuticals Inc’s Banking’s 100-Day Moving Average at 6.58: Will the Stock Break Through? - The InvestChronicle

Sep 16, 2024
pulisher
Sep 16, 2024

Zentalis clinical hold resolution came ‘no strings attached,’ says Oppenheimer - TipRanks

Sep 16, 2024
pulisher
Sep 16, 2024

Zentalis Pharma gains as FDA lifts partial clinical hold on cancer drug studies - XM

Sep 16, 2024
pulisher
Sep 16, 2024

Zentalis Shares Rise After U.S. FDA Lifts Hold on Azenosertib Studies - MarketWatch

Sep 16, 2024
pulisher
Sep 16, 2024

Zentalis Pharmaceuticals Advances with FDA Approval and Upcoming Data - TipRanks

Sep 16, 2024
pulisher
Sep 15, 2024

Zenas Biopharma IPO raises $225 mln in US IPO market - Eyes On News

Sep 15, 2024
pulisher
Sep 13, 2024

Zenas BioPharma shares rise nearly 8% in market debut - XM

Sep 13, 2024
pulisher
Sep 13, 2024

Zenas BioPharma raises $225 mln in US IPO - Reuters

Sep 13, 2024
pulisher
Sep 12, 2024

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering - GlobeNewswire

Sep 12, 2024
pulisher
Sep 10, 2024

Zenvia Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St

Sep 10, 2024
pulisher
Sep 09, 2024

Earnings call: Zenvia reports robust Q2 2024 growth, plans expansion By Investing.com - Investing.com Canada

Sep 09, 2024
pulisher
Sep 09, 2024

Earnings call: Zenvia reports robust Q2 2024 growth, plans expansion - Investing.com India

Sep 09, 2024
pulisher
Sep 07, 2024

Zenvia Inc. Complies with SEC’s September Filing - TipRanks

Sep 07, 2024
pulisher
Sep 07, 2024

Zenvia Inc. Reports Mid-Year Financial Performance - TipRanks

Sep 07, 2024
pulisher
Sep 07, 2024

Zenvia Inc. Soars with Robust Q2 2024 Earnings - TipRanks

Sep 07, 2024

Zenvia Inc Stock (ZENV) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$242.60
price up icon 0.36%
$292.49
price up icon 1.07%
$79.72
price up icon 1.70%
software_application ADP
$291.07
price up icon 0.48%
$367.32
price up icon 1.77%
$73.98
price up icon 1.07%
Cap:     |  Volume (24h):